1. Home
  2. NNNN vs SAM Comparison

NNNN vs SAM Comparison

Compare NNNN & SAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NNNN
  • SAM
  • Stock Information
  • Founded
  • NNNN 2021
  • SAM 1984
  • Country
  • NNNN Germany
  • SAM United States
  • Employees
  • NNNN N/A
  • SAM N/A
  • Industry
  • NNNN Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • SAM Beverages (Production/Distribution)
  • Sector
  • NNNN Health Care
  • SAM Consumer Staples
  • Exchange
  • NNNN Nasdaq
  • SAM Nasdaq
  • Market Cap
  • NNNN 2.2B
  • SAM 2.4B
  • IPO Year
  • NNNN 2025
  • SAM 1995
  • Fundamental
  • Price
  • NNNN $29.76
  • SAM $223.82
  • Analyst Decision
  • NNNN
  • SAM Hold
  • Analyst Count
  • NNNN 0
  • SAM 10
  • Target Price
  • NNNN N/A
  • SAM $246.11
  • AVG Volume (30 Days)
  • NNNN 82.0K
  • SAM 201.0K
  • Earning Date
  • NNNN 10-23-2025
  • SAM 10-23-2025
  • Dividend Yield
  • NNNN N/A
  • SAM N/A
  • EPS Growth
  • NNNN N/A
  • SAM N/A
  • EPS
  • NNNN 0.06
  • SAM 6.99
  • Revenue
  • NNNN $8,185,146.00
  • SAM $2,049,593,000.00
  • Revenue This Year
  • NNNN N/A
  • SAM N/A
  • Revenue Next Year
  • NNNN N/A
  • SAM $1.10
  • P/E Ratio
  • NNNN $566.20
  • SAM $31.53
  • Revenue Growth
  • NNNN 21.95
  • SAM 2.46
  • 52 Week Low
  • NNNN $5.18
  • SAM $185.34
  • 52 Week High
  • NNNN $55.65
  • SAM $329.55
  • Technical
  • Relative Strength Index (RSI)
  • NNNN 38.40
  • SAM 53.69
  • Support Level
  • NNNN $28.13
  • SAM $217.18
  • Resistance Level
  • NNNN $33.32
  • SAM $227.37
  • Average True Range (ATR)
  • NNNN 5.89
  • SAM 5.54
  • MACD
  • NNNN -0.54
  • SAM 0.41
  • Stochastic Oscillator
  • NNNN 26.27
  • SAM 76.82

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.

About SAM Boston Beer Company Inc. (The)

Boston Beer is a top player in high-end malt beverages and adjacent categories in the US, with strong positions in craft beer, flavored malt beverages, hard cider, and hard seltzer. The bulk of volume and revenue is concentrated in four brands: Samuel Adams, Angry Orchard, Twisted Tea, and Truly. Beverages are produced using a hybrid model leveraging both in-house capacities and third-party breweries through contract arrangements. While the firm is required to use distributors to reach end markets, including retailers and on-premises operators, it also employs 500 internal sales representatives to educate the market about its products. The firm generates almost all sales in the US.

Share on Social Networks: